Abstract:Introduction: Treatment of severe pneumonia after renal transplantation frequently requires a comprehensive involvement; however, therapeutic strategies remain diverse and experimental without uniform effectiveness. The aim of this study was to evaluate the safety and effectiveness of a standardized interdisciplinary protocol for severe pneumonia after renal transplantation. Methods: Data were retrospectively collected for 53 renal recipients with severe pneumonia between 2009 and 2012 in a tertiary intensive care unit. The standardized protocol involves fiberoptic bronchoscopy with bronchoalveolar lavage, broad-spectrum antibiotics therapy, aggressive immunosuppression withdrawal, intravenous corticosteroid administration, nutrition support, conservative fluid management, and mechanical ventilation support. All the patients were managed by an interdisciplinary team led by intensivists. Results: Thirty-five (66.0%) patients underwent a bronchoalveolar lavage and 24(45.3%) had a definitive etiologic diagnosis. Thirty-three (62.3%) patients received non-invasive ventilation (NIV) as initial respiratory support. Of 20 NIV treated patients with early-onset pneumonia, 12 (60%) were intubated. However, only 2 of 13 (23.1%) patients with late-onset pneumonia failed NIV in this study (P=0.005). The estimated glomerular filtration rate at ICU discharge was 65±14 mL/min, which was close to mean renal function on ICU admission (63±12 mL/min, P=0.138). No acute allograft rejection occurred. ICU mortality was 17.2% (5 of 29) in patients with early-onset pneumonia versus 4.2% (1 of 24) in those with late-onset pneumonia (P=0.946). Conclusions: Early-onset pneumonia in renal transplant recipients resulted in higher rate of NIV failure, longer duration of mechanical ventilation, and increased length of ICU and hospital stay. Our results suggest that the standardized interdisciplinary protocol might be both effective and feasible with minimal risk of graft loss.

Pharmaceutical Care for Renal Transplant Recipients with Pneumonia

Pharmaceutical Care of Pulmonary Infection After Renal Transplantation

Pharmaceutical Care for a Patient with Multiple Pulmonary Infection after Renal Transplantation

Pharmaceutical Care for Hypertensive Patients after Renal Transplantation

Pharmaceutical care for a patient with severe pneumonia treated by vancomycin

Effectiveness of Pharmaceutical Care in an Intensive Care Unit from China A Pre- and Post-Intervention Study

The application of reduced glutathione in the treaatment of severe pneumonia

Case report of clinical pharmacists participating in the treatment of Pseudomonas aeruginosa pneumonia with chronic renal failure

Pharmaceutical care for a child with congenital heart disease complicated by severe pneumonia

Participation of Clinical Pharmacists into the Treatment for Severe Community-acquired Pneumonia Patients with Multiple Organ Dysfunction Syndrome

Pharmaceutical Care for One Patient with Drug-induced Liver Failure Complicated with Pulmonary Infection by Clinical Pharmacists

THE DIAGNOSIS AND TREATMENT OF SEVERE PNEUMONIA IN KIDNEY TRANSPLANT RECIPIENTS

An Evidence-Based Interdisciplinary Protocol for Renal Transplant Recipients with Severe Pneumonia: A 4-Year Accumulated Experience.

Analysis of Eleven Cases of Severe Pneumonia in Kidney Transplant Recipients

Pneumonia secondary to immunosuppressant regimens in renal transplant patients:a retrospective analysis of 51 cases

A clinical analysis of post-renal transplant pulmonary infection

Pharmaceutical Care in Kidney Transplant Recipients: Behavioral and Physiologic Outcomes at 12 Months

Pharmaceutical Care for an Inpatient with Chronic Obstructive Pulmonary Disease

Postoperative pharmaceutical care of patients with acute myocardial infarction complication after renal transplantation

Pulmonary Infection after Kidney Transplantation:Survey and Analysis

The Clinical Study on the Combined Therapy of TCM and WM for Pneumonia Following Renal Transplantation